Fundraising FoxTesoRx Pharma
Menlo Park, US · Founded 2010 · 1 known investors
Find your way into TesoRx Pharma
8 people in our graph can introduce you to the TesoRx Pharma team.
Sign up to see every warm intro you have to TesoRx Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TesoRx Pharma team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TesoRx is a clinical-stage pharmaceutical company developing new therapies based on a proprietary drug delivery platform, focused on conditions with unmet needs and limited or sub-optimal treatment options.
Founders & leadership
TesoRx Pharma was founded in 2010 by Guru Betageri.
GB
Guru BetageriManager
WA
Willem A RobbertsChief Financial Officer and Manager
RT
Ramachandran ThirucoteFounding Chairman & Chief Executive OfficerDr. Ramachandran Thirucote is a pharmaceutical scientist with decades of experience in drug design and formulation. He previously led development of SPRIX (ketorolac nasal spray) at ROXRO Pharma, worked in early-stage development at SRI International and Agouron Pharmaceuticals, and has served as Principal Investigator on contracts with NIAID and NCI.
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2014–2019
▶$289KraisedMay 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$289KraisedMay 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Willem A RobbertsExecutive Officer, Director
- Ramachandran ThirucoteExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $289K
- First sale
- Apr 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$697.5KraisedJul 2016 · 8 investors · PharmaceuticalsRule 506(b)
▶$697.5KraisedJul 2016 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Guru BetageriDirector
- Willem A RobbertsExecutive Officer, Director
- Ramachandran ThirucoteExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $697.5K
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2014 · 3 investors · PharmaceuticalsRule 506(b)
▶$2MraisedMay 2014 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramachandran ThirucoteExecutive Officer, Director
- Guru BetageriDirector
- Willem A RobbertsExecutive Officer, Director
- Offering amount
- $10.1M
- Amount sold
- $2M
- First sale
- May 2014
- Incorporated
- Limited Liability Company, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Tarsus PharmaceuticalsTarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions. Its treatment areas include Demodex blepharitis, and it works closely with eye care professionals and patients.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
AltaThera PharmaceuticalsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Companies working in the same space as TesoRx Pharma.
Frequently asked questions
- What does TesoRx Pharma do?
- TesoRx is a clinical-stage pharmaceutical company developing new therapies based on a proprietary drug delivery platform, focused on conditions with unmet needs and limited or sub-optimal treatment options.
- Who founded TesoRx Pharma?
- TesoRx Pharma was founded by Guru Betageri in 2010.
- Who are TesoRx Pharma's investors?
- TesoRx Pharma's investors include Keiretsu Forum.
- How much funding has TesoRx Pharma raised?
- TesoRx Pharma has disclosed $3M raised across 3 rounds.
- Where is TesoRx Pharma headquartered?
- TesoRx Pharma is headquartered in Menlo Park, US.